Global Cardiac Mapping Market - Drivers, Opportunities and Forecast Analysis to 2032
Cardiac
Mapping Market Size was valued at USD 2.3 Billion in 2022.
The cardiac mapping market industry is projected to grow from USD 2.51 Billion
in 2023 to USD 4.954 Billion by 2032, at CAGR of 8.90% during the forecast
period
In the last ten years, interventional
electrophysiology has advanced dramatically. Cardiac mapping is one of the most
sophisticated methods for collecting and displaying information from an ECG.
It's defined as a method for determining the spatial and temporal distribution
of cardiac electrical signals during a specific heart beat. The data is sent to
the software, which creates a three-dimensional (3D) model of the heart,
displaying the electromagnetic waves generated during each beating. The
approach reveals the catheter's position and movement inside the heart. Cardiac
mapping is a simple process that allows doctors to locate the location of heart
chambers that are suffering arrhythmia.
New entrants into the market, increased
investments, funding, and grants, increasing incidence of target diseases, and
growth in the geriatric population are all driving factors in the cardiac
mapping industry's growth. Increased funding and grants for research and
development efforts in cardiac mapping technology, rising prevalence of target
diseases, and a growing geriatric population are all major drivers propelling
the market forward. The rise in the incidence of cardiovascular diseases among
all age groups as a result of a sedentary lifestyle and obesity, as well as the
involvement of key companies such as Abbott and Medtronic in the manufacturing
of contact mapping systems, are expected to boost the market's growth during
the forecast period.
Several advanced diagnostic technologies
introduced by medical device companies, increased demand for precise diagnosis
of critical cardiac diseases, and the availability of well-qualified
interventional cardiologists in developed economies are expected to boost the
growth of the cardiac mapping systems market over the forecast period.
Major Key
Players:
MRFR recognizes the Cardiac Mapping Market Players
are— Abbott Laboratories, GE Healthcare, Boston
Scientific Corporation, Medtronic plc., Johnson & Johnson, Koninklijke
Philips N.V., Hill-Rom Services, Inc.
Segment Analysis
The Global
Cardiac Mapping Market is divided into three categories: product, indication,
and end user.
The market has
been segmented into two categories based on product: contact cardiac mapping
systems and non-contact cardiac mapping systems. Because of its widespread
availability, contact cardiac mapping devices are expected to have the largest
market share in the worldwide cardiac mapping industry.
Atrial
fibrillation, atrial flutter, atrioventricular nodal reentrant tachycardia
(AVNRT), Wolff-Parkinson-White Syndrome (WPW), and other indications have been
divided into the cardiac mapping market. Because of the significant number of
individuals who suffer from atrial fibrillation, the sector is expected to have
the biggest market share.
Hospitals,
clinics, diagnostic centers, and others are among the end user categories of
the cardiac mapping market. As these are the principal places where patients
obtain diagnosis and treatment, hospitals are likely to hold the highest share
of the market. Due to the high frequency of cardiac arrhythmias and the growing
awareness of them in emerging nations, the segment is likely to continue its
leadership position during the projected period.
Regional Analysis
In terms of regions, cardiac mapping is expected
to be the most popular during the projected period in North America. The major
factors driving the North American market are an increase in the approval rate
of mapping systems and clinical trials validating cardiac mapping systems in
the United States, a high incidence of CVDs, a growing focus of government
organizations on providing funding for research, and an increasing geriatric
population in Canada. The market will be driven by the flexible management of
patients in US hospitals and attractive reimbursement policies for
cardiovascular disorders. Because of the integration of technology and health
care in North American health care facilities, the area is likely to remain
dominating during the projected period.
During the projection period, Europe and
Asia-Pacific are also likely to provide profitable prospects. In India and
Australia, the number of interventional cardiologists is expanding, raising
knowledge of cardiac mapping devices in those nations. This is thought to be a
key element in the market's projected expansion in Asia Pacific at a
comparatively high CAGR during the forecast period.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment